AS-252424

CAS No. 900515-16-4

AS-252424( AS252424 | AS 252424 | AS-252424 )

Catalog No. M16475 CAS No. 900515-16-4

AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 67 In Stock
10MG 123 In Stock
25MG 205 In Stock
50MG 309 In Stock
100MG 447 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AS-252424
  • Note
    Research use only, not for human use.
  • Brief Description
    AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
  • Description
    AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
  • In Vitro
    AS-252424 also inhibits PI3Kα, PI3Kβ and PI3Kδ with IC50s of 935±150 nM, 20 μM and 20 μM, respectively. AS-252424 inhibits MCP-1-mediated chemotaxis in wild-type primary monocytes in a concentration-dependent manner with an IC50 value of 52 μM, as well as in the monocytic cell line THP-1 with an IC50 value of 53 μM. In the human monocytic cell line THP-1, MCP-1 binding to the GPCR chemokine receptor CCR2, strongly induces phosphorylation of PKB/Akt, which is effectively inhibited by AS-252424 at IC50 values as low as 0.4 μM. In contrast, induction of PKB/Akt phosphorylation by colony stimulating factor (CSF-1), binding to the growth factor receptor c-fms, is only blocked by AS-252424 at IC50 values as high as 4.7 μM.
  • In Vivo
    Oral administration of AS-252424 in a mouse model of acute peritonitis leads to a significant reduction of leukocyte recruitment. To evaluate the efficacy of AS-252424 to block leukocyte migration in vivo, it is tested in a mouse model of thioglycollate-induced peritonitis. Oral administration of AS-252424 at 10 mg/kg results in moderate reduction of neutrophil recruitment (35%±14%), almost matching the result observed in PI3Kγ-deficient mice. Given the short oral half-life of AS-252424 (t1/2=1 h) and relative high clearance (2.25 L/kg per h), investigations at later time points (24-48 h) to assess macrophage and monoycyte recruitment are not undertaken. The modest pharmacokinetic properties do not appear to be caused by rapid oxidative metabolism (microsomal metabolism after 1 h: 16% (rat), 10% (human)).
  • Synonyms
    AS252424 | AS 252424 | AS-252424
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3Kγ| PI3Kα| Casein KiN/Ase 2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    900515-16-4
  • Formula Weight
    305.28
  • Molecular Formula
    C??H?FNO?S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30.5 mg/mL (100 mM)
  • SMILES
    O=C(NC/1=O)SC1=C/C2=CC=C(C3=CC=C(F)C=C3O)O2
  • Chemical Name
    (Z)-5-((5-(4-fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pomel V, et al. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem. 2006 Jun 29;49(13):3857-71.
molnova catalog
related products
  • GNE-490

    GNE-490 is a potent, selective, orally available class I PI3K inhibitor.

  • SF-1126

    SF-1126?is a pan PI3K/BRD4 inhibitor, RGDS-conjugated LY294002 prodrug that exhibits increased solubility and binds to specific integrins.

  • PI3Kδ-IN-3

    PI3Kδ-IN-3 (TC KHNS 11) is a PI3Kδ inhibitor with an IC50 value of 9 nM.PI3Kδ-IN-3 has a favorable pharmacokinetic profile and inhibits B cell function.